Indo Us Bio-Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Indo Us Bio-Tech Ltd · Outcome · 30 Oct 2026, 9:42 pm
Indo Us Bio-Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 1,505 (-51.2% YoY | -54.4% QoQ) ■ EBITDA: -260 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -17.3 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -367 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -1.83 (Profit to Loss YoY | Profit to Loss QoQ)
Original exchange filing (PDF)
More announcements from Indo Us Bio-Tech Ltd
- Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Unaudited Financial Results for the quarter ended on 30-09-2026 · 30 Oct 2026
- INDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 30 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 30 Oct 2026
- INDO US BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 30 Oct 2026
- Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve and take on record the Un-Audited .... · 30 Oct 2026
- Directors cum promoters and other promoter visit china · 23 Oct 2026
- Voting Results and Scrutinizer''s Report for passing resolutions through remote e voting in 22nd AGM of the Company · 02 Oct 2026
